Theraclion
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$2.61B
-83.0
-0.21
$2.65M
36
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company employs 36 full-time employees The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company employs 36 full-time employees The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.